Loading...
Galapagos NV
GLPG.AS•EURONEXT
HealthcareBiotechnology
€24.86
€0.22(0.89%)
Galapagos NV (GLPG.AS) Financial Performance & Statements
Review Galapagos NV’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
14.99%
↑ 14.99%
Operating Income Growth
-113.38%
↓ 113.38%
Net Income Growth
-65.01%
↓ 65.006%
Operating Cash Flow Growth
21.17%
↑ 21.17%
Operating Margin
-111.44%
↓ 111.44%
Gross Margin
84.02%
↑ 84.02%
Net Profit Margin
-58.83%
↓ 58.83%
ROE
-5.94%
↓ 5.94%
ROIC
-8.96%
↓ 8.96%
Galapagos NV (GLPG.AS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Galapagos NV stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $75.50M | $59.85M | $77.87M | $62.43M |
| Cost of Revenue | $15.74M | $19000.00 | $16.56M | $2.55M |
| Gross Profit | $59.76M | $59.83M | $61.32M | $59.88M |
| Gross Profit Ratio | $0.79 | $1.00 | $0.79 | $0.96 |
| R&D Expenses | $97.19M | $93.05M | $73.61M | $71.61M |
| SG&A Expenses | $3.69M | $46.58M | $33.14M | $30.79M |
| Operating Expenses | $122.48M | $114.14M | $106.75M | $102.40M |
| Total Costs & Expenses | $138.22M | $114.15M | $123.31M | $104.95M |
| Interest Income | $17.22M | $23.13M | $23.71M | $25.71M |
| Interest Expense | -$499000.00 | $695000.00 | $285000.00 | $254000.00 |
| Depreciation & Amortization | $0.00 | $5.86M | $4.28M | $5.83M |
| EBITDA | $19.13M | -$48.45M | $4.97M | -$27.30M |
| EBITDA Ratio | $0.25 | -$0.81 | $0.06 | -$0.44 |
| Operating Income | -$62.72M | -$54.30M | -$45.43M | -$42.52M |
| Operating Income Ratio | -$0.83 | -$0.91 | -$0.58 | -$0.68 |
| Other Income/Expenses (Net) | $81.75M | $5.16M | $42.27M | $56.07M |
| Income Before Tax | $19.03M | -$49.14M | $4.09M | $22.93M |
| Income Before Tax Ratio | $0.25 | -$0.82 | $0.05 | $0.37 |
| Income Tax Expense | -$93000.00 | -$571000.00 | -$571000.00 | -$568000.00 |
| Net Income | $25.31M | -$50.43M | $8.98M | $90.22M |
| Net Income Ratio | $0.34 | -$0.84 | $0.12 | $1.45 |
| EPS | $0.29 | -$0.77 | $0.14 | $1.37 |
| Diluted EPS | $0.38 | -$0.77 | $0.14 | $1.37 |
| Weighted Avg Shares Outstanding | $87.55M | $65.90M | $65.90M | $65.90M |
| Weighted Avg Shares Outstanding (Diluted) | $66.03M | $65.90M | $65.90M | $65.90M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan